Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7341)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 7, 2022 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu MY, Yeh ML, Huang CI, Wang SC, Tsai YS, Tsai PC, Ko YM, Lin CC, Chen KY, Wei YJ, Hsu PY, Hsu CT, Jang TY, Liu TW, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World J Gastroenterol 2022; 28(1): 140-153 [PMID: 35125824 DOI: 10.3748/wjg.v28.i1.140] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v28/i1/140.htm |
| Number | Citing Articles |
| 1 |
Jin Lei, Sibo Yang, Bowen Chen, Linzhi Zhang, Tao Yan, Gangqi Yang, Yue Chen, Yinyin Li, Yinying Lu, Shi Zuo. Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 357 doi: 10.2147/JHC.S392347
|
| 2 |
Gui-Ji Lv, Dong Ji, Lingxiang Yu, Hong-Yan Chen, Jing Chen, Mengwen He, Wen-Chang Wang, Hong-Bo Wang, Christopher Tsang, Jianjun Wang, Ming-Lung Yu, George Lau, George Lau, Masao Omaya, Jidong Jia, Hui Zhuang, Yu-Mei Wen, Xinxin Zhang, Jin Mo Yang, Tawesak Tanwandee, Diana Payawal, Saeed Hamid, S. K. Sarin, Jing Chen, Dong Ji, Wenhong Zhang, Fusheng Wang, Jiangao Fan, Lungen Lu, Xiaoguang Dou, Xiaolong Qi, Qin Ning, Hong You, Hong Ren, Jian Sun, Ming-Lung Yu, Jacob George, George B. B. Goh, Sang Hoon Ahn, Rino Alvani Gani, Mohd Ismail Merican, Khin Maung Win, Oidov Baatarkhuu, Hasmik Ghazinyan, Manal H. El-Sayed, Anuchit Chutaputti, Phunchai Charatcharoenwitthaya, Pei-jer Chen, Jia-Horng Kao, Rosmawati Mohamed, Rakhi Maiwall, Manoj Kumar, Rakesh Aggarwal, Alexander Thompson, Yoon Jun Kim, Grace Wong, Fu Gao, Gang Li, Jun-Qi Niu, Yu Wang, Zhi-Liang Gao. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis. Hepatology International 2024; 18(5): 1459 doi: 10.1007/s12072-024-10700-7
|
| 3 |
Longgang Zhao, Xinyuan Zhang, Brenda M. Birmann, Christopher J. Danford, Michelle Lai, Tracey G. Simon, Andrew T. Chan, Edward L. Giovannucci, Long Ngo, Towia A. Libermann, Xuehong Zhang. Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom. International Journal of Cancer 2024; 155(9): 1593 doi: 10.1002/ijc.35054
|
| 4 |
Chun-Jen Liu, Wai Kay Seto, Ming-Lung Yu. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD. Hepatology International 2024; 18(S2): 897 doi: 10.1007/s12072-024-10699-x
|
| 5 |
Paula Fernández-Alvarez, María Fernanda Guerra-Veloz, Angel Vilches-Arenas, Patricia Cordero-Ruíz, Francisco Bellido-Muñoz, Angel Caunedo-Alvarez, Isabel Carmona-Soria. Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients. Viruses 2023; 15(6): 1251 doi: 10.3390/v15061251
|
| 6 |
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents. Frontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1227317
|
| 7 |
Patrícia Rocha Martins, Kátia Luciano Pereira Morais, Nayane Alves de Lima Galdino, Adriana Jacauna, Sálua O. C. Paula, Wagner C. S. Magalhães, Luciana W. Zuccherato, Larissa S. Campos, Paulo Guilherme O. Salles, Kenneth J. Gollob. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49441-2
|
| 8 |
Hamidreza Karimi-Sari, Damani A Piggott, Eileen P Scully, Kathleen Ward, Catherine G Sutcliffe, Mark Sulkowski, Oluwaseun Falade-Nwulia. Changes in Inflammatory Cytokines After Chronic Hepatitis C Treatment Among People Living With HIV. Open Forum Infectious Diseases 2024; 11(1) doi: 10.1093/ofid/ofad623
|
| 9 |
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053
|
| 10 |
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication. Clinical and Molecular Hepatology 2024; 30(3): 326 doi: 10.3350/cmh.2024.0155
|
| 11 |
Ming-Lun Yeh, Jee-Fu Huang, Ming-Lung Yu. Metabolic Steatotic Liver Disease. 2024; : 261 doi: 10.1016/B978-0-323-99649-5.00008-X
|